• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Crystallization and X-ray analysis of monodisperse human properdin.单分散人备解素的结晶及X射线分析
Acta Crystallogr F Struct Biol Commun. 2019 Feb 1;75(Pt 2):0. doi: 10.1107/S2053230X18018150. Epub 2019 Jan 23.
2
Functional and structural insight into properdin control of complement alternative pathway amplification.关于备解素对补体替代途径放大作用的功能和结构见解。
EMBO J. 2017 Apr 13;36(8):1084-1099. doi: 10.15252/embj.201696173. Epub 2017 Mar 6.
3
Structural Basis for Properdin Oligomerization and Convertase Stimulation in the Human Complement System.补体系统中备解素寡聚化和转化酶刺激的结构基础。
Front Immunol. 2019 Aug 22;10:2007. doi: 10.3389/fimmu.2019.02007. eCollection 2019.
4
Insights Into Enhanced Complement Activation by Structures of Properdin and Its Complex With the C-Terminal Domain of C3b.补体因子 P 的结构及其与 C3b C 末端结构域复合物增强补体激活的研究进展
Front Immunol. 2019 Sep 4;10:2097. doi: 10.3389/fimmu.2019.02097. eCollection 2019.
5
Expression and characterisation of the thrombospondin type I repeats of human properdin.人备解素I型血小板反应蛋白重复序列的表达与特性分析
Biochim Biophys Acta. 2001 Aug 13;1548(2):265-77. doi: 10.1016/s0167-4838(01)00238-2.
6
Characterization of mutant forms of recombinant human properdin lacking single thrombospondin type I repeats. Identification of modules important for function.缺乏单个I型血小板反应蛋白重复序列的重组人备解素突变体形式的表征。对功能重要模块的鉴定。
J Immunol. 1995 Dec 15;155(12):5777-85.
7
Neutron and X-ray scattering studies on the human complement protein properdin provide an analysis of the thrombospondin repeat.对人补体蛋白备解素的中子和X射线散射研究提供了对血小板反应蛋白重复序列的分析。
Biochemistry. 1991 Aug 13;30(32):8000-8. doi: 10.1021/bi00246a018.
8
The dimeric and trimeric solution structures of the multidomain complement protein properdin by X-ray scattering, analytical ultracentrifugation and constrained modelling.通过X射线散射、分析型超速离心和受限建模得到的多结构域补体蛋白备解素的二聚体和三聚体溶液结构。
J Mol Biol. 2004 Nov 5;343(5):1327-43. doi: 10.1016/j.jmb.2004.09.001.
9
Molecular architecture of human properdin, a positive regulator of the alternative pathway of complement.补体替代途径的正向调节因子——人备解素的分子结构
J Biol Chem. 1984 Apr 10;259(7):4582-8.
10
A recombinant two-module form of human properdin is an inhibitor of the complement alternative pathway.重组双模块形式的人备解素是补体替代途径的抑制剂。
Mol Immunol. 2016 May;73:76-87. doi: 10.1016/j.molimm.2016.03.005. Epub 2016 Apr 6.

引用本文的文献

1
Characterization of the bispecific VHH antibody tarperprumig (ALXN1820) specific for properdin and designed for low-volume administration.针对备解素的双特异性 VHH 抗体 tarperprumig(ALXN1820)的特性描述,该抗体专为小体积给药而设计。
MAbs. 2024 Jan-Dec;16(1):2415060. doi: 10.1080/19420862.2024.2415060. Epub 2024 Oct 13.
2
Structure determination of an unstable macromolecular complex enabled by nanobody-peptide bridging.通过纳米抗体-肽桥实现不稳定的大分子复合物的结构测定。
Protein Sci. 2022 Oct;31(10):e4432. doi: 10.1002/pro.4432.
3
Structural studies offer a framework for understanding the role of properdin in the alternative pathway and beyond.结构研究为理解备解素在替代途径中的作用及其以外的作用提供了一个框架。
Immunol Rev. 2023 Jan;313(1):46-59. doi: 10.1111/imr.13129. Epub 2022 Sep 13.
4
Nanobodies Provide Insight into the Molecular Mechanisms of the Complement Cascade and Offer New Therapeutic Strategies.纳米抗体为补体级联反应的分子机制提供了新的见解,并为新的治疗策略提供了思路。
Biomolecules. 2021 Feb 17;11(2):298. doi: 10.3390/biom11020298.
5
Properdin oligomers adopt rigid extended conformations supporting function.备解素寡聚体采取刚性伸展构象以支持其功能。
Elife. 2021 Jan 22;10:e63356. doi: 10.7554/eLife.63356.
6
Soluble collectin-12 mediates C3-independent docking of properdin that activates the alternative pathway of complement.可溶性凝集素 12 介导 C3 非依赖性衔接物因子 B 的结合,从而激活补体替代途径。
Elife. 2020 Sep 10;9:e60908. doi: 10.7554/eLife.60908.
7
Structural Basis for Properdin Oligomerization and Convertase Stimulation in the Human Complement System.补体系统中备解素寡聚化和转化酶刺激的结构基础。
Front Immunol. 2019 Aug 22;10:2007. doi: 10.3389/fimmu.2019.02007. eCollection 2019.

本文引用的文献

1
Parsimonious Charge Deconvolution for Native Mass Spectrometry.简约电荷去卷积用于天然质谱。
J Proteome Res. 2018 Mar 2;17(3):1216-1226. doi: 10.1021/acs.jproteome.7b00839. Epub 2018 Feb 8.
2
Functional and structural insight into properdin control of complement alternative pathway amplification.关于备解素对补体替代途径放大作用的功能和结构见解。
EMBO J. 2017 Apr 13;36(8):1084-1099. doi: 10.15252/embj.201696173. Epub 2017 Mar 6.
3
Complement in disease: a defence system turning offensive.补体系统在疾病中的作用:防御系统转为进攻。
Nat Rev Nephrol. 2016 Jul;12(7):383-401. doi: 10.1038/nrneph.2016.70. Epub 2016 May 23.
4
Complement activation, regulation, and molecular basis for complement-related diseases.补体激活、调节及补体相关疾病的分子基础。
EMBO J. 2015 Nov 12;34(22):2735-57. doi: 10.15252/embj.201591881. Epub 2015 Oct 21.
5
Structural basis for the stabilization of the complement alternative pathway C3 convertase by properdin.补体替代途径 C3 转化酶稳定性的稳定素结构基础。
Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13504-9. doi: 10.1073/pnas.1309618110. Epub 2013 Jul 30.
6
Mimer: an automated spreadsheet-based crystallization screening system.Mimer:一种基于电子表格的自动化结晶筛选系统。
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2013 Jul;69(Pt 7):815-20. doi: 10.1107/S1744309113014425. Epub 2013 Jun 29.
7
Integration, scaling, space-group assignment and post-refinement.整合、缩放、空间群确定及后续精修。
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):133-44. doi: 10.1107/S0907444909047374. Epub 2010 Jan 22.
8
The dimeric and trimeric solution structures of the multidomain complement protein properdin by X-ray scattering, analytical ultracentrifugation and constrained modelling.通过X射线散射、分析型超速离心和受限建模得到的多结构域补体蛋白备解素的二聚体和三聚体溶液结构。
J Mol Biol. 2004 Nov 5;343(5):1327-43. doi: 10.1016/j.jmb.2004.09.001.
9
Solvent content of protein crystals.蛋白质晶体的溶剂含量。
J Mol Biol. 1968 Apr 28;33(2):491-7. doi: 10.1016/0022-2836(68)90205-2.
10
Analysis of the natural polymeric forms of human properdin and their functions in complement activation.人类备解素的天然聚合形式分析及其在补体激活中的作用
J Immunol. 1989 Jan 1;142(1):202-7.

单分散人备解素的结晶及X射线分析

Crystallization and X-ray analysis of monodisperse human properdin.

作者信息

Pedersen Dennis Vestergaard, Revel Margot, Gadeberg Trine Amalie Fogh, Andersen Gregers Rom

机构信息

Department of Molecular Biology and Genetics, Aarhus University, Gustav Wiedsvej 10C, DK-8000 Aarhus, Denmark.

出版信息

Acta Crystallogr F Struct Biol Commun. 2019 Feb 1;75(Pt 2):0. doi: 10.1107/S2053230X18018150. Epub 2019 Jan 23.

DOI:10.1107/S2053230X18018150
PMID:30713161
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6360440/
Abstract

The 54 kDa protein properdin, also known as factor P (FP), plays a major role in the complement system through the stabilization of the alternative pathway convertases. FP circulates in the blood as cyclic dimers, trimers and tetramers, and this heterogeneity challenges detailed structural insight into the mechanism of convertase stabilization by FP. Here, the generation of an intact FP monomer and a variant monomer with the third thrombospondin repeat liberated is described. Both FP monomers were excised from recombinant full-length FP containing internal cleavage sites for TEV protease. These FP monomers could be crystallized, and complete data sets extending to 2.8 Å resolution for the intact FP monomer and to 3.5 Å resolution for the truncated variant were collected. The principle of specific monomer excision and domain removal by the insertion of a protease cleavage site may be broadly applicable to structural studies of oligomeric, flexible and modular proteins.

摘要

54千道尔顿的备解素蛋白,也称为因子P(FP),通过稳定替代途径转化酶在补体系统中发挥主要作用。FP以环状二聚体、三聚体和四聚体的形式在血液中循环,这种异质性对深入了解FP稳定转化酶的机制提出了挑战。在此,描述了完整FP单体和释放出第三个血小板反应蛋白重复序列的变体单体的产生。两种FP单体均从含有TEV蛋白酶内部切割位点的重组全长FP中切除。这些FP单体可以结晶,并收集了完整FP单体分辨率高达2.8埃、截短变体分辨率高达3.5埃的完整数据集。通过插入蛋白酶切割位点进行特异性单体切除和结构域去除的原理可能广泛适用于寡聚、柔性和模块化蛋白质的结构研究。